Levomenol
Identification
- Generic Name
- Levomenol
- DrugBank Accession Number
- DB13153
- Background
Bisabolol, or more formally α-(−)-bisabolol or also known as levomenol, (-)-alpha-Bisabolol is found in fats and oils. (-)-alpha-Bisabolol is isolated from essential oil of Matricaria chamomilla (German chamomile) (-)-alpha-Bisabolol belongs to the family of Sesquiterpenes. These are terpenes with three consecutive isoprene units.
- Type
- Small Molecule
- Groups
- Approved, Experimental
- Structure
- Weight
- Average: 222.372
Monoisotopic: 222.198365457 - Chemical Formula
- C15H26O
- Synonyms
- (-)-alpha-Bisabolol
- alpha-(-)-bisabolol
- alpha-bisabolol
- Bisabolol
- Kamillosan
- Levomenol
- α-(−)-bisabolol
- External IDs
- FEMA NO. 4666
Pharmacology
- Indication
Levomenol has been known to elicit a number of potentially beneficial pharmacological effects, including anti-irritant, anti-inflammatory, and anti-microbial actions. Bisabolol is also demonstrated to enhance the percutaneous absorption of certain molecules
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.
- Pharmacodynamics
Levomenol is an anti-inflammatory and natural moisturizing agent that has been found to diminish the signs of photodamage, reduce pruritus, and ameliorate skin texture and elasticity.
- Mechanism of action
- Not Available
- Absorption
The purpose of the present investigations was to study the cutaneous absorption of sesquiterpenic alcohol, the major active principle of chamomile. For these investigations 14C-labelled levomenol ((-)-6-methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol; (-)-alpha-bisabolol) was prepared by biochemical incorporation of [14C]-acetate into the molecule. 5 h after topical application of the radiolabelled substance onto nude mice half of the radioactivity was found in the skin. The other part was measured in tissue and organes. 90% of this radioactivity was analysed as intact levomenol.
- Volume of distribution
To demonstrate the distribution of the substance in the skin a part of this tissue was cutted into horizontal slices by a cryotome. From the slices autoradiograms were produced. The densitometric measuration showed that there was a fast penetration of levomenol into the skin. 5 h after the topical application the substance was displaced from outermost to innermost areas. From these results a fast cutaneous absorption and a long therapeutical effect of the antiphlogistic and spasmolytic levomenol in the skin can be expected.
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareFilgotinib The serum concentration of Levomenol can be increased when it is combined with Filgotinib. Roxadustat The serum concentration of Levomenol can be increased when it is combined with Roxadustat. Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice.Learn more - Food Interactions
- No interactions found.
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image IASO White Science EX Serum Liquid 0.02 g/1mL Topical Iaso Inc 2011-02-05 2018-03-12 US IASO White Science EX Toner Liquid 0.02 g/1mL Topical Iaso Inc 2011-02-01 2018-03-12 US Neogen Dermalogy White Truffle Laycure Oi L Stick 0.05 g/10g Topical Outin Futures Corp. 2016-11-01 2017-10-31 US PurpleU BAOBAB FACE Oil 0.07 g/15mL Topical Recipe Co., Ltd. 2017-10-01 Not applicable US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Intense Multi Ampoule Balm Vita C Levomenol (0.05 g/10g) + alpha-Tocopherol acetate (0.3 g/10g) Liquid Topical Nature Republic Co., Ltd. 2022-03-01 Not applicable US NEWSTEM Rx IPL VITA C Energy Ampoule Levomenol (0.5 g/100g) + Adenosine (0.04 g/100g) + Ascorbic acid (13.5 g/100g) Liquid Topical Yj Lab Co., Ltd. 2022-01-02 Not applicable US Seamoms Tamanu Oil Mist Levomenol (0.5 g/100mL) + Adenosine (0.04 g/100mL) Oil Topical Oneskin Cosmetics Co., Ltd. 2021-01-27 Not applicable US Sensicutan - Salbe Levomenol (0.3 g) + Heparin sodium (20000 IU) Ointment Topical Harras Pharma Curarina Arzneimittel Gmb H 2001-12-07 Not applicable Austria - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image IASO White Science EX Serum Levomenol (0.02 g/1mL) Liquid Topical Iaso Inc 2011-02-05 2018-03-12 US IASO White Science EX Toner Levomenol (0.02 g/1mL) Liquid Topical Iaso Inc 2011-02-01 2018-03-12 US Intense Multi Ampoule Balm Vita C Levomenol (0.05 g/10g) + alpha-Tocopherol acetate (0.3 g/10g) Liquid Topical Nature Republic Co., Ltd. 2022-03-01 Not applicable US Neogen Dermalogy White Truffle Laycure Oi L Levomenol (0.05 g/10g) Stick Topical Outin Futures Corp. 2016-11-01 2017-10-31 US NEWSTEM Rx IPL VITA C Energy Ampoule Levomenol (0.5 g/100g) + Adenosine (0.04 g/100g) + Ascorbic acid (13.5 g/100g) Liquid Topical Yj Lab Co., Ltd. 2022-01-02 Not applicable US PurpleU BAOBAB FACE Levomenol (0.07 g/15mL) Oil Topical Recipe Co., Ltd. 2017-10-01 Not applicable US Seamoms Tamanu Oil Mist Levomenol (0.5 g/100mL) + Adenosine (0.04 g/100mL) Oil Topical Oneskin Cosmetics Co., Ltd. 2021-01-27 Not applicable US
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as sesquiterpenoids. These are terpenes with three consecutive isoprene units.
- Kingdom
- Organic compounds
- Super Class
- Lipids and lipid-like molecules
- Class
- Prenol lipids
- Sub Class
- Sesquiterpenoids
- Direct Parent
- Sesquiterpenoids
- Alternative Parents
- Tertiary alcohols / Hydrocarbon derivatives
- Substituents
- Alcohol / Aliphatic homomonocyclic compound / Bisabolane sesquiterpenoid / Hydrocarbon derivative / Organic oxygen compound / Organooxygen compound / Sesquiterpenoid / Tertiary alcohol
- Molecular Framework
- Aliphatic homomonocyclic compounds
- External Descriptors
- sesquiterpenoid (CHEBI:125) / Bisabolane sesquiterpenoids, Bisabolanes (C09621) / Bisabolane sesquiterpenoids (LMPR0103060001)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 24WE03BX2T
- CAS number
- 23089-26-1
- InChI Key
- RGZSQWQPBWRIAQ-CABCVRRESA-N
- InChI
- InChI=1S/C15H26O/c1-12(2)6-5-11-15(4,16)14-9-7-13(3)8-10-14/h6-7,14,16H,5,8-11H2,1-4H3/t14-,15+/m1/s1
- IUPAC Name
- (2S)-6-methyl-2-[(1S)-4-methylcyclohex-3-en-1-yl]hept-5-en-2-ol
- SMILES
- [H][C@@]1(CCC(C)=CC1)[C@@](C)(O)CCC=C(C)C
References
- General References
- External Links
- KEGG Compound
- C09621
- PubChem Compound
- 442343
- PubChem Substance
- 347829263
- ChemSpider
- 390796
- BindingDB
- 50382730
- 19461
- ChEBI
- 125
- ChEMBL
- CHEMBL1096927
- ZINC
- ZINC000001849759
- Wikipedia
- Bisabolol
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 1 Completed Treatment Onychomycosis 1 1 Completed Treatment Wounds and Injuries 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Liquid Topical 0.02 g/1mL Liquid Topical Stick Topical 0.05 g/10g Oil Topical 0.07 g/15mL Oil Topical Ointment Topical - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.0729 mg/mL ALOGPS logP 4.76 ALOGPS logP 3.91 Chemaxon logS -3.5 ALOGPS pKa (Strongest Basic) -0.47 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 1 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 20.23 Å2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 72.19 m3·mol-1 Chemaxon Polarizability 28.29 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available
Transporters
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- Actions
- Substrate
- General Function
- Sodium-independent organic anion transmembrane transporter activity
- Specific Function
- Mediates the Na(+)-independent uptake of organic anions such as pravastatin, taurocholate, methotrexate, dehydroepiandrosterone sulfate, 17-beta-glucuronosyl estradiol, estrone sulfate, prostagland...
- Gene Name
- SLCO1B1
- Uniprot ID
- Q9Y6L6
- Uniprot Name
- Solute carrier organic anion transporter family member 1B1
- Molecular Weight
- 76447.99 Da
References
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- Actions
- Substrate
- General Function
- Sodium-independent organic anion transmembrane transporter activity
- Specific Function
- Mediates the Na(+)-independent uptake of organic anions such as 17-beta-glucuronosyl estradiol, taurocholate, triiodothyronine (T3), leukotriene C4, dehydroepiandrosterone sulfate (DHEAS), methotre...
- Gene Name
- SLCO1B3
- Uniprot ID
- Q9NPD5
- Uniprot Name
- Solute carrier organic anion transporter family member 1B3
- Molecular Weight
- 77402.175 Da
References
Drug created at November 20, 2016 03:12 / Updated at February 21, 2021 18:54